Calidi Biotherapeutics Inc. (CLDI)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $2.29M
Last updated: Nov 17, 2026 at 11:03 AM ET
Calidi Biotherapeutics Inc. (CLDI) Earnings: Report Dates and Results
In the quarter ended Sep 30, 2026, Calidi Biotherapeutics reported EPS of -$1.47. It beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Next Report
CLDI's next report is not on the earnings calendar yet.
Earnings History
Of the 9 quarters below that had an estimate, CLDI beat 3 and missed 6. The widest gap in the table came in the quarter ended Sep 30, 2023, when EPS landed 210.93% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$1.47 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 13, 2026 |
| Jun 30, 2026 | -$2.94 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 13, 2026 |
| Sep 30, 2025 | -$2.21 | -$1.68 | -$1.68 - -$1.68 | -31.55% | Miss | N/A | 1 | 0 up, 1 down | Nov 13, 2025 |
| Jun 30, 2025 | -$1.99 | -$1.32 | -$1.32 - -$1.32 | -50.76% | Miss | N/A | 1 | 0 up, 0 down | Aug 8, 2025 |
| Mar 31, 2025 | -$2.25 | -$1.80 | -$1.80 - -$1.80 | -25.00% | Miss | N/A | 1 | 0 up, 0 down | Apr 4, 2025 |
| Dec 31, 2024 | -$0.27 | -$0.09 | N/A | -200.00% | Miss | N/A | 2 | 0 up, 0 down | Mar 31, 2025 |
| Sep 30, 2024 | -$7.80 | -$10.26 | -$13.09 - -$7.44 | +23.98% | Beat | N/A | 2 | 0 up, 0 down | Nov 12, 2024 |
| Jun 30, 2024 | -$16.80 | -$17.40 | -$19.00 - -$9.60 | +3.45% | Beat | N/A | 2 | 0 up, 0 down | Aug 13, 2024 |
| Mar 31, 2024 | -$23.71 | -$32.40 | N/A | +26.82% | Beat | N/A | 2 | 0 up, 0 down | May 14, 2024 |
| Dec 31, 2023 | -$0.48 | -$0.20 | -$0.21 - -$0.20 | -140.00% | Miss | N/A | 2 | 0 up, 0 down | Mar 19, 2024 |
| Sep 30, 2023 | -$63.43 | -$20.40 | N/A | -210.93% | Miss | -317250.0% | N/A | N/A | Nov 14, 2023 |
| Jun 30, 2023 | -$0.43 | N/A | N/A | N/A | N/A | -408.6% | N/A | N/A | Aug 30, 2023 |
| Mar 31, 2023 | -$27.02 | N/A | N/A | N/A | N/A | -54148.2% | N/A | N/A | Jun 28, 2023 |
| Dec 31, 2022 | -$0.26 | N/A | N/A | N/A | N/A | -273.3% | N/A | N/A | Mar 30, 2023 |
| Sep 30, 2022 | $0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2022 |
| Jun 30, 2022 | $0.14 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 28, 2022 |
| Mar 31, 2022 | $0.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 28, 2022 |
| Dec 31, 2021 | $0.15 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 29, 2022 |
| Sep 30, 2021 | -$0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 29, 2021 |
| Jun 30, 2021 | Not reported | N/A | N/A | N/A | Not reported | N/A | N/A | N/A | Sep 28, 2021 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2024 was -$48.58, after -$91.37 the year before. It was $0.12 for the year ended Dec 31, 2021, the oldest of the 4 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2024 | -$48.58 | N/A |
| Dec 31, 2023 | -$91.37 | N/A |
| Dec 31, 2022 | -$0.05 | -141.7% |
| Dec 31, 2021 | $0.12 | N/A |
Frequently Asked Questions About CLDI
How often does CLDI beat earnings estimates?
Calidi Biotherapeutics beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate, with an average surprise of -49.13%.
CLDI pages: Overview, Earnings, Financials, Competitors